Binding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (¿2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings.
Published April 11, 2018 · Recall initiated: March 9, 2018
Summary
FDA records medical device Class II recall Z-1301-2018, published April 11, 2018 and initiated March 9, 2018. Recalling firm: The Binding Site Group, Ltd.; Status: Terminated; Reported quantity: 20 kits distributed to the U.S.; Lot: Lot 407460, UDI 05051700017688. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- The Binding Site Group, Ltd.
- Distributor
- US Distribution was made to CA. There was no foreign/military/government distribution.
- Lot
- Lot 407460, UDI 05051700017688
- Risk classification
- Class II
- Area (FDA)
- device
- Country
- United Kingdom
Related recalls
- FDABrand Name: EXENT Analyser Product Name: EXENT Analyser Model/Catalog Number: IE800.A Software Version: 1.0.20June 17, 2026
- FDAThe Optilite Clinical Chemistry Analyzer. IVD. Model Number: IE700. UDI-05051700017176 - Product Usage: TheMay 27, 2020
- FDAOPTILITE IgM Kit, REF: NK012.OPT.A, IVD, UDI: 05051700017565February 26, 2020
- FDABinding Site Human IgM Kit (for SPAPLUS), REF: NK012.S The device consists of reaction buffer, sheep anti-IgMDecember 19, 2018
- FDALeadCare Plus Blood Lead Analyzer Part Number: 82-0001 Intended for the quantitative measurement of lead in aApril 11, 2018
- FDAA.L.P.S. MIS Calcaneus Locking Plate LG RT F.A.S.T. Guide inserts, Item Number: 816209003,UDI:April 11, 2018
Questions about this recall
Was Binding Site Optilite Beta-2-Microglobulin Urine Kit, Ref LK043.L.OPT.A, IVD. The firm name on the label is The Binding Site Group Ltd., Birmingham, U.K. The Optilite Beta-2-Microglobulin (¿2M) Urine kit is intended for the quantitative in-vitro measurement of beta-2-microglobulin in urine using the Binding Site Optilite analyser to aid in the diagnosis of active rheumatoid arthritis and kidney disease. This test should be used in conjunction with other laboratory and clinical findings. recalled?
Yes. FDA published recall Z-1301-2018 on April 11, 2018. Reported hazard: The product is not meeting the antigen excess protection claim of up to 760mg/L, as stated in the Instructions for Use.
What should I do if I have this product?
Voluntary: Firm initiated · Letter